Home > Books > Clinical Trials in Psychopharmacology: A Better Brain
Clinical Trials in Psychopharmacology: A Better Brain
View PDF

Clinical Trials in Psychopharmacology: A Better Brain

Publication Year: 2010
Edition: 2nd
Authors/Editor: Hertzman, Marc and Adler, Lawrence
Publisher: Wiley
ISBN: 978-0-470-74076-7
  • Description
  • Details

The authors take a critical look at recent developments and present a series of trenchant and challenging observations

Although clinical trials were virtually unheard of in psychiatry for many years, they are now the gold standard for judging whether drugs are safe and useful. But should they be? What is the true status of clinical trials? Even when they ostensibly demonstrate a benefit of a certain treatment, the strict patient selection criteria, poor compliance and high drop-out rate leave the conclusions open to question. Are the new treatments really better or more cost-effective than the old? Do they have fewer side effects?

Clearly written, this book provides immediate access to new developments across the spectrum of drug testing. It's provocative reading for psychiatrists, pharmacologists and all those interested in improved drug treatments for patients with mental illness.

Section I examines the significant changes in law and the regulatory environment that have occurred during the past ten years. Has fossilization handicapped the US Food and Drug Administration in promoting treatment advances? How can the plethora of findings be regulated? This is particularly pertinent in genomic studies and there are two chapters addressing the impact of genomics on psychiatric research. This section also addresses the role of women in drug trials – a group long excluded but now demanding a part, for without testing how can optimal treatments be devised?

The next two Sections highlight clinical trials in the major areas of psychiatric pharmacological treatment, including Mood Disorders, especially Bipolar, Anxiety Disorders, and addictions. Chapters on pharmacological treatments for Eating Disorders, Attention Deficit Disorder, Autism and Asperger’s Syndrome, and Impulse Control Disorder represent the latest thinking on these subjects.

The final Section contains a consummate example of out-of-the [Western]- box thinking, namely consideration of herbal medicines – used by a large number of patients, with or without medical supervision. We conclude with a close look at the problem of side effects, then selected thoughts about methodology.

Clearly written, the text provides immediate access to new developments across the spectrum of drug testing. Clinical Trials in Psychopharmacology: A Better Brain is provocative reading for psychiatrists, pharmacologists and all those interested in improved drug treatments for patients with mental illness.

  • Platform:
    Ovid
  • Publisher: Wiley
  • Product Type: Book
  • Author/Editor: Hertzman, Marc and Adler, Lawrence
  • ISBN: 978-0-470-74076-7
  • Specialty:
    Psychopharmacology
  • Language: English
  • Edition: 2nd
  • Pages: 406
  • Illustrations: 0
  • Year: 2010

Free Instant Access
This Month

JOTM
Ovid Emcare A premium nursing and allied health database ideal for practice, research, or education.
JOTM
PsycBOOKS® A database of peer-reviewed scholarly and professional books published by the American Psychological Association.
JOTM
Journal of Physical Therapy Education The premier forum for disseminating scholarly works in physical therapy educational theory and practice.
JOTM
Circulation Peer-reviewed reports on clinical and laboratory research relevant to cardiovascular disease.

Noteworthy

Doody's Featured Books
Greenfield's Surgery: Scientific Principles and Practice
The gold standard in the field of surgery, covers new technologies, innovative techniques, and integrating new scientific knowledge with evolving changes in surgical care.

Walsh & Hoyt's Clinical Neuro-Ophthalmology: The Essentials
Widely acknowledged as the definitive reference in the field, this title brings you the practical, hands-on information you need to effectively evaluate and manage neuro-ophthalmic conditions.